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ScienceDirectSingle-cell analyses allow uncovering cellular heterogeneity,
not only per se, but also in response to viral infection. Similarly,
single cell transcriptome analyses (scRNA-Seq) can highlight
specific signatures, identifying cell subsets with particular
phenotypes, which are relevant in the understanding of virus–
host interactions.
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Introduction
Recent technological advances coupled with mathematical
modeling and computer science revolutionized the field of
biology. Indeed, deep sequencing of the whole human
genome in 2001 signed a first milestone in the ‘omics era’
[1,2]. From that point on, lot of efforts have been devoted to
develop new chemistries and devices with high throughput
capacity, such as Next Generation Sequencing (NGS) and
Mass Spectrometry (MS), and to bring them to basic and
clinical research [3,4]. The combination of multiple omics
is known today as the ‘integrome’ and should allow a better
and more comprehensive understanding of biological pro-
cesses or diseases [5].
To date, a series of state of the art techniques is available for
studies at population level resolution, with many biological
applications, including cancer [6], stem cells [7], and infec-
tious diseases [8,9]. These omic studies are likely to be
valuable assets for personalized medicine [10–12].
Although essential and informative, population studies
have some limitations as they contain a mixture of cells.
As such, these cells can appear on one hand as being
similar or homogeneous for some parameters, such as cell
size or shape, tissue localization, protein expression or cellwww.sciencedirect.com type subset. On the other hand, a cell population can also
appear heterogeneous for some other parameters, such as
cell cycle or metabolic activation. Thus, analyses at the
cell population level may average and minimize individual
cellular differences, potentially masking rare cells or cell
subsets with a significant specific phenotype [13]. Illus-
trations of this can be found in cancer, where heterogene-
ity in intra-tumor cells at genetic, epigenetic and pheno-
typic level can lead to resistance in cancer therapies, as
well as in infectious diseases where cell heterogeneity can
reveal differential susceptibility to infections or different
immunological responses [14,15,16]. In order to start
investigating this cellular heterogeneity, single-cell anal-
yses were initially performed using imaging techniques
and further developed to benefit from sequencing tech-
nologies [14,17]. Single-cell analyses bring up several
technical challenges, including single cell isolation, han-
dling minimal amounts of biological sample (6 pg of DNA,
10 pg of RNA), and data normalization and analysis [5,17–
22]. Nowadays, an array of kits and methods are available,
overcoming these challenges and allowing single cell
omics analyses (reviewed in [23–26]).
Characterization of cell heterogeneity in the field of
virology is obviously of great interest as it is likely
impacting virus replication cycle and thus infection out-
come. Indeed, the success of viral replication is highly
dependent on its host, as viruses adapted to exploit the
cell machinery to their own benefit. Interestingly, achiev-
ing universal infection in a given cell population is quite
rare. Two non-mutually exclusive hypotheses can explain
this unequal susceptibility to infection: (i) viral heteroge-
neity, that is, the presence of a mixture of competent,
mutated and defective viral particles, displaying differ-
ences in infection ability, and (ii) cellular heterogeneity,
that is, the presence of a mixture of cells with differences
in metabolism, composition, activation status or cell cycle,
resulting in specific cellular environments shaping virus
progression success throughout the cell. In this perspec-
tive, single-cell analyses represent novel opportunities to
identify specific cellular and molecular features promot-
ing or in contrast restricting virus replication, thereby
adding to the understanding of virus–host interactions, as
well as providing new targets to inhibit viral replication.
To date, only a limited amount of single cell studies in
virology have been published (reviewed in [14,27]).
Initial studies used single-cell technologies to explore
virus evolution, through methods including fluorescentCurrent Opinion in Virology 2018, 29:39–50
40 Viral pathogenesisreporters, FACS analysis and sorting, as well as time lapse
microscopy (recently reviewed in [27]), and it is only
recently that transcriptome analyses at single cell level
started to uncover cell subsets with specific response to
viral infection. In this review, we will focus on the
prominent role of single-cell RNA-Seq (scRNA-Seq) in
virus–host interactions. In particular, we will provide an
overview of the complete scRNA-Seq workflow as well as
studies using this technology to identify specific features
relevant for virus–host interactions.
Transcriptome analysis: single cell RNA-Seq
workflow
The scRNA-Seq analysis pipeline can be divided in three
essential steps (Figure 1): (i) single cell isolation, (ii)
RNA-Seq procedure, that is, RNA extraction, reverse
transcription (RT), library preparation and sequencing,
and (iii) data analysis.
Single cell isolation
In order to perform single-cell RNA-Seq (scRNA-Seq)
the first trivial step is to isolate single cells. To date single
cell isolation methods can be divided according to two
criteria: (i) the cell isolation capacity, that is, high or low
throughput, depending of the level of automation and (ii)
the cell selection method, that is, blind selection without
any a priori or biased selection according to a specific
parameter (Table 1). For example, some high throughput
technologies such as Fluorescence Activated Cell Sorting
(FACS) and Magnetic Activated Cell Sorting (MACS)
allow a biased selection of the cell population based either
on cell size and shape or on the expression of specific cell
surface markers, while microfluidics-based and microdro-
plets-based technologies allow unbiased separation of
single cells. Similarly, low throughput techniques that
require micromanipulation, such as manual cell picking or
Laser Capture Microdissection (LCM), also allow biased
cell selection based on a specific cell morphology or the
expression of a fluorescence marker. By contrast, limiting
dilution-based methods are unbiased. (For more informa-
tion on the isolation methods, please refer to [27–
29,30].)
RNA-Seq procedure: RNA extraction, reverse
transcription, library preparation, and sequencing
Standard protocols for library preparation have been
optimized to use only a few ng (10–100 ng) of starting
DNA material. However, one single cell contains on
average only 10 pg of total RNA. Therefore, workflows
for RNA extraction and library preparation were adapted
and optimized to work with single-cell material.
Isolated single cells need first to be lysed in order to
access RNA. This step can be performed through dedi-
cated automated devices (such as fluidigm C1, 10X geno-
mics chromium, ddSEQ single-cell isolator), or manually,
using commercially available kits (such as GenEluteTMCurrent Opinion in Virology 2018, 29:39–50 Single Cell RNA Purification Kit (Sigma) or Single Cell
Lysis Kit (Thermo Scientific)). Alternatively, manual cell
lysis and total RNA purification can be performed simul-
taneously using resin-based columns (e.g. Single Cell
RNA Purification Kit (NorGen Biotek Corp), PicoPure1
RNA Isolation Kit (Thermo Scientific)) or magnetic bead
separation (e.g. 5 min Single Cell RNA Extraction Kit
(Biofactories)). Afterwards, RNA is enriched for mRNA,
either by polyA selection or more rarely by ribosome
depletion (Table 2, Figure 1) [31,32]. The enriched
RNA fraction is then usually reverse transcribed with
modified oligodT primer through different protocols,
either polyA tailing or template switching. During the
RT step, some protocols allow tagging of single molecules
with unique molecular identifiers (UMI), which are ran-
dom hexanucleotides that can be used to quantify more
precisely the number of initial mRNA molecules present
in one single cell [33,34]. Following reverse transcription,
cDNA is amplified by in vitro transcription or by PCR.
The amplified cDNA library is then used for library
preparation and high throughput sequencing (currently
most protocols use Nextera for library preparation and
Illumina as a sequencing platform) (for additional infor-
mation on RNA-Seq procedures, please refer to
[3,15,23,25,29,35,36,37]).
Single-cell data analysis
As every single cell is unique, it is not possible to perform
experimental replicates and assess noise. It is thus essen-
tial to have some quality controls to ensure data reliabil-
ity. This can be achieved by adding synthetic mRNAs of
known sequence and amount, such as External RNA
Controls Consortium (ERCC) RNA spike-ins, to each
cell lysate. The number of reads recovered from the
spike-ins will provide information about inter-sample
technical variability [3,25,38,39].
It has been recently shown that sequencing errors in UMI
sequence are common [34], and may thus bias transcript
quantification when used. To minimize the error rate of
UMI during sequencing, Lau et al. developed a new
approach consisting in building a high error resistant
exponentially-expanded barcodes (EXBs) with giga-scale
diversity and introduce them into double strand cDNA by
mean of a transposase [40]. Multiple packages for single-
cell data analysis are already available and many compu-
tational tools are being developed to improve current
analyses in order to handle bona fide cell-to-cell variation
and technical noise [38,39,41,42,43,44,45,46]. Most
of these analyses rely on cell-to-cell vicinity, or transcrip-
tome similarity, thereby allowing a neighborhood-based
graphical representation of individual cells, such as Prin-
cipal Component Analysis (PCA) or t-distributed Stochas-
tic Neighbor Embedding (t-SNE) plots. These plots are
commonly used as they allow easy and intuitive visuali-
zation of cell heterogeneity and cell clusters that can be
further analyzed by differential expression analysis.www.sciencedirect.com
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Figure 1
Specific Transcriptional and
Molecular Signatures
Current Opinion in Virology
Identification of specific cell signatures using single-cell RNA-seq and phenotypic analyses. The whole analysis pipeline can be divided in five
steps. (i) Cells infected at population level are separated and isolated as single cells. (ii) Each individual cell is processed for RNA-Seq, requiring
RNA extraction, reverse transcription (RT) with optional unique molecular identifier (UMI) barcoding, library preparation and amplification, and
www.sciencedirect.com Current Opinion in Virology 2018, 29:39–50
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Table 1
Single cell isolation method.
Throughput Technique Cell selection Parameters of population
enrichment
Number of cells Final volume/
cell
High FACS Biased Cell morphology/size, specific cell
surface marker expression, reporter
gene expression
Hundreds Microliters
MACS Biased Specific cell surface marker
expression
Hundreds Microliters
Microfluidics (i.e. Fluidigm C1, 10X
genomics chromium)
Unbiased – Hundreds to
thousands
Nanoliters
Microdroplets (i.e. ddSEQ Single-Cell
Isolator)
Unbiased – Thousands Nanoliters
Low Micromanipulation (manual cell picking,
laser capture microdissection)
Biased Cell morphology reporter gene
expression
Tens Microliters
Limiting dilution Unbiased – Tens MicrolitersIn conclusion, transcriptome analysis at single-cell level
(scRNA-Seq) can reveal cell heterogeneity in a cell
population, thereby highlighting the existence of one
or multiple discrete cell clusters with specific gene
expression profiles.
Identification of a cell-specific transcriptional
signature correlating with a specific
phenotype in response to viral infection
Although valuable, scRNA-Seq alone does not provide
any information on the association and relevance of a
specific cell cluster (with a specific gene expression
signature) with a specific cell phenotype. For this pur-
pose, identification and assessment of a specific pheno-
type in response to viral infection is required.
Phenotypic analyses usually rely, either on the expression of
a virus reporter gene or a specific cellular gene, or on the
activity of a specific cellular protein (Figure 1). Further-
more, phenotypic analyses can be performed either at
single-cell level associated with scRNA-Seq or at population
level independently of scRNA-Seq. Indeed, assessment of
the phenotype of interest on the same single cell that will be
lysed and processed for scRNA-Seq allows for direct over-
lapping of transcriptome and phenotype, thereby providing(Figure 1 Legend Continued) finally sequencing. (iii) Sequencing reads are
sequences to assess abundance and structure of transcripts, thereby defini
transcriptomic analyses can be performed to inform about data structure an
Distributed Stochastic Neighbor Embedding (t-SNE) or Principal Componen
provide specific gene expression profiles. Finally, single cell transcriptomes
RT-qPCR analyses. These three first steps characterize the process for sing
cellular heterogeneity in a cell population, that is, identifying one or multiple
direct association with corresponding scRNA-Seq) or using two cell popula
transcriptome analyses. Phenotypic analyses include assessment of protein
immunofluorescence or western blots, or assessment of protein activity stu
(channels) or translocation assays (metabolites). The analysis of specific ph
displaying different levels of protein expression or activity) or differences be
transcriptomic data and phenotypical analyses should help identifying spec
defined transcriptional and molecular signature.
Current Opinion in Virology 2018, 29:39–50 a direct and straightforward association between gene
expression signature and specific phenotype. This is possi-
ble if single cells are first characterized by FACS or by
microscopy for the expression of a fluorescent reporter gene
before scRNA-Seq for example. Alternatively, specific phe-
notypes of interest need to be first characterized at popula-
tion level. In this case, it will be helpful to identify two cell
populations with extreme opposite phenotypes. For exam-
ple, a cell population A is more permissive than a cell
population B. Single-cell analysis of the two cell populations
may then reveal imbalanced cell clustering, correlating with
the observed phenotypes. For example, the cell population
A contains a higher proportion of cells in cluster 3 and only
few cells in the other two clusters, while cell population B
contains only a few cells in cluster 3 and a higher proportion
of cells in the other clusters. Cells in cluster 3 will thus
represent permissive cells and will be characterized by a
specific transcriptional signature.
In conclusion, joint analysis of scRNA-Seq profiles and
phenotype assessment brings additional and valuable
information, as it allows correlating a specific cell phe-
notype to a transcriptional signature (Figure 1). These
analyses should help identifying novel biomarkers spe-
cific for viral phenotypes. further processed and aligned to host and virus genome reference
ng the gene expression profile of each single cell. Multiple
d cell heterogeneity using dimensionality reduction plots, such as t-
t Analysis (PCA). Cell clustering and differential expression analysis can
 can be compared to cell population transcriptome or to quantitative
le-cell transcriptomic analysis, allowing mostly revealing the level of
 cell subpopulations. (iv) Phenotypic analyses at single cell level (with
tions with extreme opposite phenotypes can complement
 expression level and localization, using FACS staining,
dies, using assays quantifying enzymatic activity, transport activity
enotypes should also reveal single cell heterogeneity (i.e. single cells
tween multiple cell populations. (v) Finally, correlation analysis between
ific cell subsets displaying a specific phenotype and characterized by a
www.sciencedirect.com
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Table 2
ScRNA-Seq workflow.
RNA-Seq procedurea Advised single
cell isolation method
Starting material RT UMIb Amplification cDNA coverage
mRNA-Seq
(Tang’s method) [61]
Any PolyA selected RNA PolyA Tailing No PCR Full-length with 30-end biases
Quartz-Seq [62] Any PolyA selected RNA PolyA Tailing No PCR Full-length with 30-end biases
SC3-Seq [63] Any PolyA selected RNA PolyA Tailing No PCR Full-length with 30-end biases
SUPer-Seq [31] Any Ribosome depleted RNA Poly-dA Tailing No PCR Full-length
MATq-Seq [32] Any Ribosome depleted RNA Poly-dC Tailing Yes PCR Full-length
SMART-Seq [64] Any PolyA selected RNA Template Switching No PCR Full-length
SMART-Seq 2 [65] Any PolyA selected RNA Template Switching No PCR High coverage full-length
STRT-Seq [66] Microdroplet PolyA selected RNA Template Switching Yes PCR Fragments <500 bp 50-end
(TSS) biases
Drop-Seq [67] Microdroplet PolyA selected RNA Template Switching No PCR Strong 30 end biases
Cel-Seq [68] Microdroplet PolyA selected RNA PolyA Tailing Yes In vitro transcription (IVT)-based Strong 30 end biases
Cel-Seq 2 [69] Microdroplet PolyA selected RNA PolyA Tailing Yes In vitro transcription (IVT)-based Strong 30 end biases
In-Drop [70] Microdroplet PolyA selected RNA PolyA Tailing Yes In vitro transcription (IVT)-based Strong 30 end biases
MARS-Seq [71] Microdroplet PolyA selected RNA PolyA Tailing Yes In vitro transcription (IVT)-based Strong 30 end biases
a SC3-Seq (single-cell mRNA 3-prime end sequencing); MATq-Seq (multiple annealing and dC-tailing-based quantitative single-cell RNA-Seq); SMART-Seq (Switching mechanism at 5’ End of RNA
Template); STRT-Seq (Single cell tagged reverse transcription sequencing); Cel-Seq (Cell Expression by Linear amplification); MARS-Seq (Massive parallel RNA single cell sequencing framework).
b Unique Molecular Identifiers.
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44 Viral pathogenesisSingle-cell RNA-Seq in virology
To date, a few single-cell RNA-Seq studies have been
performed, investigating virus or cell diversity (Table 3).
In 2013, McWilliam Leitch and McLauchlan published
the first scRNA-Seq analysis in virology, aiming at explor-
ing the heterogeneity of Hepatitis C virus (HCV) qua-
sispecies and assessing their fitness [47]. They isolated
16 Huh7 single cells that express constitutively JFH1_2a
subgenomic replicon, extracted total RNA and amplified
a 708 bp-specific N5B region by RT-qPCR. The PCR
products were then cloned and 20 clones per single cell
were sequenced, providing a total of 320 viral sequences.
They showed that one single cell harbored on average
113 copies of viral RNA and that the sequence of HCV
quasispecies differed extensively among cells, with some
single cells displaying only WT viral RNA sequences
while others contained up to four different viral RNA
sequences, and diverse mutations. These data
highlighted the co-existence of multiple quasi-species
within the same single cell, suggesting distinct individual
viral evolution, likely due to mutations introduced during
genome replication by the error-prone RNA-dependent
RNA polymerase. Furthermore, fitness analysis of three
major variants was compared to the prevalent WT repli-
con and showed that the best replicative fitness was
displayed by the WT replicon, consistent with a selective
advantage for WT replication and its high prevalence.
In 2015 Wu et al. developed a dedicated pipeline called
mRNA amplification and library construction system
(MIRALCS) to investigate both cellular and viral RNA
of the tumoral HeLa S3 cell line, originally transformed
by Human Papilloma Virus (HPV) [48]. scRNA-Seq
analysis revealed a high degree of heterogeneity among
individual virus-infected cells. In particular, they identi-
fied alternative splicing of HPV genome, resulting either
in internal E6 splicing leading to a truncated and non-
functional E6 protein, or in aberrant HPV-host sequence
fusion transcripts. Furthermore, coupling transcriptomic
data with co-expression analysis identified a set of
283 genes co-regulated with E6 and E7, representing
novel potential HPV interactors.
Tsioris et al. used microengraving to identify and capture
West Nile Virus (WNV)-specific actively secreting and
memory B cells isolated from 11 WNV-infected individ-
uals, followed by single cell RT-PCR and sequencing of
WNV-specific antibodies (V, D, J, CDR3 sequences of
heavy and light immunoglobulin chains) [49,50]. They
successfully identified and isolated 98 WNV-specific cells
out of thousands of cells and identified complete antibody
sequence from 19 single cells. Phenotypic analyses were
carried out to characterize the diverse antibodies, using
Plaque Reduction Neutralization Assay and binding affin-
ity to WNV Envelope protein. This strategy successfully
led to the identification of four novel WNV neutralizing
antibodies.Current Opinion in Virology 2018, 29:39–50 Afik et al. developed T cell receptor (TCR) Reconstruc-
tion Algorithm for Paired-End Single cell (TRAPeS), an
algorithm facilitating reconstruction of full-length TCR
sequences from scRNA-Seq-derived short reads, in order
to investigate TCR heterogeneity among CD8+ T cells
[51]. Their analysis revealed that naı¨ve CD8+ T cells
expressed distinct TCR, thereby suggesting a heteroge-
neous population, while effector memory CD8+ T cells
displayed some levels of oligoclonality. Similarly, virus-
exposed CD8+ T cells, during vaccination protocols or
chronic infections, presented various degrees of heteroge-
neity. Indeed, Yellow Fever Virus (YFV) and Hepatitis C
virus (HCV)-exposed CD8+ T cells (short-term exposure
during vaccination protocol) displayed higher levels of
TCR heterogeneity than cytomegalovirus (CMV)-
exposed cells (long-term exposure during persistent infec-
tion). These data suggest that TCR heterogeneity and cell
oligoclonality were negatively correlated and depended on
the duration of virus exposure. ScRNA-Seq data of 353 sin-
gle cells were further explored to assess cell heterogeneity
of CMV and YFV-exposed CD8+ T cells. The analysis
clearly separated clusters of naı¨ve CD8+ T cells, effector
CD8+ T cells and CMV-specific CD8+ T cells. By con-
trast, YFV-specific CD8+ T cells displayed some cellular
heterogeneity, with one effector memory-like subpopula-
tion and one naı¨ve-like subpopulation. Further analysis
revealed that YFV-specific CD8+ T cell subpopulations
were associated with a distinct TCR sequence, displaying
longer CDR3 sequences in the naı¨ve-like subset.
Recently, two studies used scRNA-Seq to investigate
Zika virus (ZIKV)-mediated neuropathogenesis [52,53].
First, Nowakosky and colleagues used scRNA-Seq to
characterize the gene expression profile of multiple cell
types of the developing human cortex, in order to corre-
late ZIKV tropism and pathogenesis [52]. In particular,
they evaluated the expression of 23 gene candidates
potentially involved in ZKV across cell types and identi-
fied AXL as being highly expressed in radial glial cells, in
astrocytes, in microglia and in endothelial cells. Further
analysis of AXL expression was performed by immuno-
staining of multiple tissues, including iPSC-derived cere-
bral organoids, highlighting AXL expression in radial glia
(ventricular zone staining) and neural stem cells. AXL
expression pattern seemed thus consistent with cells
susceptible to ZIKV infection and cerebral lesions (micro-
cephaly and ocular lesions), further arguing for a possible
role of AXL in ZIKV entry.
Onorati et al. established cells lines derived from neuroe-
pithelial stem (NES) cells isolated from primary neocortex
(NCX) or from spinal cord (SC) in order to investigate ZIKV
infection success according to tropism and gene expression
profile (scRNA-Seq) [53]. They confirmed previous data
showing high expression of AXL in NES cells and radial
glial cells, as well as preferential localization of ZIKV-
infected cells at the ventricular zone. ZIKV infection ofwww.sciencedirect.com
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Table 3
ScRNA-Seq studies in virology.
Virusa Cell type Single cell
isolation
Nb of single
cells analyzed
RNA sample RNA-Seq
method
Additional
transcriptomic
analysis
Phenotypic analysis Reference
HCV Huh-7 cell line,
expressing JFH-1_2a
strain
Limiting
dilution
16 vRNA RNA
extraction:
RNeasy micro
kit (Qiagen);
gene-specific
qRT-PCR
(N5B); Cloning
into
sequencing
vectors
Bulk RNA-Seq; RT
qPCR
Replicative fitness
analysis
McWilliam
Leitch and
McLauchlan,
2013 [47]
Key findings/outcome:
– Presence of an average of 113 copies of HCV replicons per cell
– Assessment of viral sequence heterogeneity (i.e. viral quasispecies) in each single cell, present at various frequencies
– Distinct single cells provide local compartments with different selective environments shaping distinct viral sequence evolution
– The predominant quasispecies in each single cell was the one displaying the best fitness
HPV HeLa S3 cell line,
transformed by HPV
infection
MIRALCS 40 Cell RNA and
vRNA
MIRALCS;
SMART-Seq2
(modified)
Bulk RNA-Seq RT-
qPCR;
Transcriptomic co-
expression analysis
Cell cycle Wu et al.,
2015 [48]
Key findings/outcome:
– Average number of mRNA molecules in HeLa S3 was 152 000
– Cell heterogeneity at cell cycle (G2/M and non-G2/M cells)
– Cell heterogeneity at the transcriptome level, with differences in gene expression, alternative splicing isoforms, and fusion transcripts
– Splice variant heterogeneity in HPV sequences, resulting in truncated E6 proteins or in HPV-host chimeric transcripts
– Identification of 283 E6–E7 co-regulated genes as novel candidates potentially interacting with HPV proteins
WNV Primary memory B
cells and antibody-
secreting cells,
isolated from infected
individuals
Micro-
engraving
19 Cell RNA
(antibody
coding
sequence: V,
D,J; CDR3)
Micro-
engraving;
gene-specific
single-cell RT-
PCR
Bulk RNA-Seq Immunoassay to
identify WNV-specific
cells
WNV Ab
characterization
(Plaque reduction
neutralization assay,
Immunoblot and
antigen affinity
assays).
Humoral response
analysis
Tsioris et al.,
2015 [49]
Key findings/outcome:
– Identification of four novel WNV neutralizing antibodies, with determined coding sequence
– Frequency assessment of WNV-specific B cells (30 cells per 100 000 peripheral blood mononuclear cells)
– Persistence of WNV antibodies and no predictive value for disease severity
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Table 3 (Continued )
Virusa Cell type Single cell
isolation
Nb of single
cells analyzed
RNA sample RNA-Seq
method
Additional
transcriptomic
analysis
Phenotypic analysis Reference
YFV
CMV
HCV
Human and murine
CD8+ T cells
FACS sorting 513 Cell RNA (TCR
repertoire)
SMART-Seq2 Bulk RNA-Seq Single cell Surface
marker expression
(FACS); Tetramer
binding assay
(fluorescence
staining)
Afik et al.,
2017 [51]
Key findings/outcome:
– Analysis of TCR repertoire diversity
– Naı¨ve CD8+ T cells express unique TCR, YFV- and HCV-specific CD8+T cells displayed a higher TCR repertoire diversity compared to CMV-specific CD8+ T cells
which are oligoclonal (poor TCR diversity)
– Correlation between TCR diversity, oligoclonality, and duration of virus exposure
– Identification of two YFV-specific CD8+ T cell subsets (effector memory-like and naı¨ve-like)
– Correlation between YFV-specific CD8 +T cells differentiation state and CDR3 length (naı¨ve cells have longer CDR3 sequences)
ZIKV Primary cells from
human cortex
(astrocytes, radial
glia, intermediate
progenitor cells,
neurons), iPSC-
derived cerebral
organoids
Micro-
dissection
and Fluidigm
715 Cell RNA SMARTer1
UltraTM Low
RNA Kit
Immunostaining of
candidate markers
(immunohisto-
chemistry)
Nowakoski
et al.,
2015 [52]
Key findings/outcome:
– Expression of AXL, a candidate gene involved in ZIKV entry, in radial glia, astrocytes, endothelial cells and microglia
– Characterization of AXL expression in cerebral and organoid samples
ZIKV Neuroepithelial stem
(NES) cells
Neurocortical cells
and Radial Glia Cells
Fluidigm 1009 Cell RNA SMARTer1
UltraTM Low
RNA Kit
Immuno-
fluorescence
staining; Immunoblot;
Immunoelectron
microscopy
Onorati et al.,
2016 [53]
Key findings/outcome:
– Establishment and scRNA-Seq characterization of neuroepithelial stem (NES) cell lines as model for in vitro ZIKV studies
– Expression and localization analysis of AXL and TYRO3, genes potentially involved in ZIKV entry in NES cells and Radial Glia
– ZIKV may impair mitosis and survival of NES cells by inducing the relocation of pTBK1 from mitotic centrosomes to mitochondria
CMV Glioblastoma tumors
and glioblastomacell
lines
Sequences
downloaded
from previous
study ([55],
SMART-Seq)
854 Cell RNA and
vRNA
Bulk RNA-Seq Johnson et al.,
2017 [54]
Key findings/outcome:
– Lack of CMV expression in glioblastoma tumors and cell lines
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Table 3 (Continued )
Virusa Cell type Single cell
isolation
Nb of single
cells analyzed
RNA sample RNA-Seq
method
Additional
transcriptomic
analysis
Phenotypic analysis Reference
HIV Dendritic Cells (DCs)
from HIV-1 Elite
Controller (EC)
individuals
FACS sorting 139 Cell RNA FACS analysis on
surface marker;
Functional
characterization of
DCs; Validation on
healthy cDCs
Martin-Gayo
et al.,
2016 [56]
Key findings/outcome:
– Presence of 3 clusters in cDCs from Elite controllers
– Characterization of a highly functional subset of cDCs with antiviral profile (high expression of Interferon-stimulated genes, costimulatory molecules and cytokines
– High expression of CD64 and PD-L1, correlating with improved immune response to HIV
HIV Primary CD4+T cells,
with extreme
phenotypes of HIV
permissiveness (high
vs low permissive
cells)
Fluidigm 166 Cell RNA SMART-Seq2 Bulk RNA-Seq Immunoprofiling; Cell
surface protein
expression (FACS
immunoprofiling);
Activation assays;
Infection assays
Rato et al.,
2017 [57]
Key findings/outcome:
– CD4+ T cell heterogeneity was driven by T cell activation
– Cell heterogeneity appeared as a continuum of transcriptional cell states rather than distinct clusters
– Correlation analysis of scRNA-Seq, protein expression, activation and permissiveness to HIV identified markers of HIV permissiveness
– HIV permissive cells displayed low levels of genes involved in interferon I pathway or in defense response pathway
HIV Primary model of
latently infected CD4
+ T cells
Fluidigm 224 Cell RNA and
vRNA
SMART-Seq2 Bulk RNA-Seq Fluorescence based
protein expression
analysis (FACS and
microscopy)
Golumbeanu
et al.,
2017 [58]
Key findings/outcome:
– Latent CD4+ T cells were heterogeneous, with two distinct cell clusters
– Latent CD4+ T cells displayed differential response to TCR-mediated stimulation
– Transcriptional heterogeneity was linked to viral reactivation potential
a HCV: Hepatitis C Virus; HPV: Human Papilloma Virus; WNV: West Nile Virus; ZKV: Zika Virus; CMV: Cytomegalovirus; YFV: Yellow Fever Virus; HIV: Human Immunodeficiency Virus.
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48 Viral pathogenesisorganotypic brain slices confirmed the absence of infected
cells in the cortical plate and the preferential infection of
cells residing in the ventricular zone such as radial glial cells.
Over time, a progressive disruption of radial glia scaffold
and disorganization of the neocortical structure was
observed, consistent with brain damage. They also investi-
gated the role of TNAK-binding kinase 1 (TBK1), previ-
ously involved in innate immunity and cell proliferation, in
NES cell growth arrest and cell death. Although scRNA-
Seq data did not reveal any difference in TBK1 gene
expression, fetal cortex analyses revealed a higher level
of phosphorylated TBK1 (pTBK1) in the ventricular zone.
Furthermore, ZIKV infection relocated pTBK1 from
mitotic centrosomes to the mitochondria in NES-infected
cells, resulting in mitosis disruption and increased cell
death, and consistent with ZIKV-mediated cerebral lesions.
Johnson et al. performed scRNA-Seq on glioblastoma
tumors and glioblastoma cell lines, previously reported
to be heterogenous, in order to investigate a possible role
of CMV infection in glioblastoma [54,55]. The analysis of
854 single cells failed to detect CMV transcripts, suggest-
ing either the absence or the rarity of CMV sequences.
Therefore, these data indicated that glioblastoma tumors
may not contain active CMV.
Recent studies on the Human Immunodeficiency Virus
(HIV) used single-cell RNA-Seq to identify the transcrip-
tional signature of specific cell subsets, such as dendritic
cells from elite controllers, highly permissive CD4+ T cells
or inducible latently infected CD4+ T cells [56–58]. Mar-
tin-Gayo et al. characterized conventional dendritic cells
(cDCs) isolated from elite controllers, at the single-cell
level, in order to understand if these cells contributed to
the improved response observed in these individuals
[56,59]. Using scRNA-Seq, they identified three cDC
subsets after HIV exposure: one subset similar to control
unexposed cells, one subset of exposed cDCs, and a third
exposed cDC subset with a different expression profile,
showing upregulated antiviral response (interferon-stimu-
lated genes and cytokines) and effective antigen-presenting
properties. This third functional subset was enriched in
elite controllers compared to chronic progressors and unin-
fected individuals, and may thus contribute to the improved
immunological control observed in elite controllers.
Rato et al. identified two CD4+ T cell populations (iso-
lated from two individuals) that, upon TCR-mediated
stimulation, displayed high and low permissiveness to
HIV infection [57]. scRNA-Seq analysis of non-infected
activated CD4+ T cells revealed transcriptional hetero-
geneity, with individual cells reflecting a continuum of
cell states and correlating with cellular activation status.
High permissive cells contained more individual cells
with successful activation profile than low permissive
cells. Analysis of cell surface protein expression was
further assessed by FACS and correlated withCurrent Opinion in Virology 2018, 29:39–50 permissiveness to HIV. Correlation analysis of scRNA-
Seq, cell activation, protein expression and HIV permis-
siveness identified candidate cellular markers marking
HIV permissive cells. A few of these biomarkers were
further validated as biomarkers of HIV permissiveness.
Subsequent transcriptome analysis of biomarker-sorted
cell subpopulations identified specific transcriptional fea-
tures associated with supported viral replication. In par-
ticular, highly permissive cells displayed downregulated
expression of 95 genes involved in antiviral response.
Using a similar approach, Golumbeanu et al. investigated
the cell heterogeneity of HIV-infected cells during latent
and activated stages, in a primary model of latently
infected CD4+ T cells [58,60]. Using a virally-encoded
fluorescent reporter gene to assess successful induction of
HIV expression coupled with scRNA-Seq analysis,
Golumbeanu et al. identified two cell subsets, with differ-
ential responsiveness to cell stimulation and HIV reacti-
vation. One cell cluster displayed globally higher gene
expression levels, and was more susceptible to cellular
stimulation and HIV expression than the other cell cluster.
Differential expression analysis also identified a 134 gene-
specific signature to discriminate the two cell subsets.
Conclusions
Overall, scRNA-Seq is a powerful technique allowing
characterizing cellular heterogeneity within a cell popu-
lation. Association of transcriptome profilings with spe-
cific cellular phenotypes may help identifying specific
proteins or biomarkers of interest involved in virus–host
interactions, such as antibodies, TCR, virus receptor or
cell-specific biomarkers.
Current analyses capture a unique snapshot of a single-
cell gene expression profile at a specific time point, and do
not allow manipulation of a single cell with follow-up
analyses over time. Future technical improvements may
possibly overcome this limitation, at least partially. Fur-
thermore, development of novel protocols allowing simul-
taneous analysis of multiple molecular molecules, such as
DNA, RNA and proteins, within the same individual cell
would provide an additional step toward a more compre-
hensive ‘single-cell integrome’, which will likely be
instrumental to further our understanding of viral repli-
cation and virus–host interactions.
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